Advanced Enzyme Technologies Limited — Updates, 02-08-2025: Press Release

Advanced Enzyme Technologies delivered robust financial results for the quarter. Revenue climbed 20% year-over-year to ₹185.9 Cr, with Profit After Tax up 16% to ₹40.4 Cr. Growth was primarily fueled by Human Nutrition (+21% to ₹122.1 Cr, boosted by Pharma/API) and Animal Nutrition (+51% to ₹26.0 Cr). Domestic sales significantly rose 32%. The company is actively expanding its B2C footprint in India with the new Wellfa nutraceutical brand, investing in R&D, and pursuing strategic acquisitions. It's also advancing new probiotic solutions and biocatalysis for API manufacturing. Bio-processing segment saw a 6% decline.